Trends in Hospital Admissions for and Readmissions After Cardiac Implantable Electronic Device Procedures in the United States: An Analysis From 2010 to 2014 Using the National Readmission Database.


Journal

Mayo Clinic proceedings
ISSN: 1942-5546
Titre abrégé: Mayo Clin Proc
Pays: England
ID NLM: 0405543

Informations de publication

Date de publication:
04 2019
Historique:
received: 14 08 2018
revised: 22 09 2018
accepted: 17 10 2018
pubmed: 12 3 2019
medline: 16 10 2019
entrez: 12 3 2019
Statut: ppublish

Résumé

To evaluate inpatient trends in de novo complete cardiac implantable electronic device (CIED) procedures and subsequent all-cause 30-day readmissions in the United States. We accessed the National Readmission Database to identify CIED implantation-related hospitalizations between January 1, 2010, and December 31, 2014, using International Classification of Diseases, Ninth Revision, Clinical Modification procedure codes. In-hospital mortality and postprocedure all-cause 30-day readmissions were also analyzed. During the study period, a total of 800,250 CIED implantation hospitalizations were identified across the United States, with an in-hospital mortality rate of 0.9% (7423 of 800,250) and a 29% decrease in CIED-related index hospitalizations (188,086 in 2010 vs 134,276 in 2014). The all-cause 30-day readmission rate for the entire cohort was 13% (106,505 of 800,250), decreasing from 14% (26,134 of 188,085) in 2010 to only 13% (17,154 of 134,276) by 2014. Dual-chamber pacemakers were the most frequently implanted in-hospital CIEDs (473,615 of 800,250 [59%]). The most common cause for readmission was heart failure exacerbation, which remained unchanged over the study period. Our data reveal a steady decline in overall in-hospital CIED implantations and only a modest decline in readmission rates. The cause for this decline may be an impact of medical and regulatory changes guiding CIED implantations, but it deserves further investigation.

Identifiants

pubmed: 30853259
pii: S0025-6196(18)30991-1
doi: 10.1016/j.mayocp.2018.10.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

588-598

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Auteurs

Deepak Kumar Pasupula (DK)

Department of Medicine, University of Pittsburgh Medical Center, PA. Electronic address: 84pdeepak@gmail.com.

Arun Rajaratnam (A)

Department of Medicine, University of Pittsburgh Medical Center, PA.

Rohit Rattan (R)

Department of Medicine, University of Pittsburgh Medical Center, PA.

Muhammad Bilal Munir (MB)

Department of Medicine, University of Pittsburgh Medical Center, PA.

Shahzad Ahmad (S)

Department of Medicine, University of Pittsburgh Medical Center, PA.

Evan Adelstein (E)

Department of Cardiac Electrophysiology, Albany Medical Center, NY.

Sandeep Jain (S)

Heart and Vascular Institute, University of Pittsburgh Medical Center, PA.

Norman C Wang (NC)

Heart and Vascular Institute, University of Pittsburgh Medical Center, PA.

Samir Saba (S)

Heart and Vascular Institute, University of Pittsburgh Medical Center, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH